![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
-Hydroxylation Activity and Mechanism-Based Inactivation
Department of Pharmacology, University of Michigan (H.L., P.F.H.), and Department of Anesthesiology, Veteran Affairs Health Service (H.Z., L.W.), Ann Arbor, Michigan
Four mutants of Thr-205 in cytochrome P450 2B1 were constructed and
expressed in Escherichia coli. The Ser-, Ala-, and Val-mutants
displayed stable reduced CO difference spectra and were able to metabolize
7-ethoxy-4-(trifluoromethyl)coumarin, testosterone, androstenedione, and
benzphetamine. The Arg-mutant displayed an unstable reduced CO difference
spectrum at 450 nm, was concomitantly converted to a denatured form with a
peak at 422 nm, and showed no catalytic activity with any of the four
substrates tested. The Ser-mutant displayed activity and metabolite profiles
for testosterone and androstenedione similar to those of the wild-type P450
2B1 (WT). Substitution of Thr-205 with Ala or Val markedly suppressed the
16
-hydroxylation activity but exhibited little effect on the
16
-hydroxylation activity for testosterone and androstenedione. Because
16
-hydroxylation activity of androgens is a specific P450 2B subfamily
marker and residue 205 is located in the F helix, which forms the ceiling of
the active site, we postulate that the
-hydroxyl side chain of Thr may
play an important role in directing the 16
-face of testosterone and
androstenedione toward the active site. Surprisingly, the Val-mutant retained
full activity for benzphetamine demethylation. When mechanism-based
inactivators for P450 2B1 were used to evaluate the susceptibility to
inactivation, the Val-mutant was resistant to inactivation by
17
-ethynylestradiol and less sensitive to inactivation by
2-ethynylnaphthalene compared with the WT enzyme. Our results demonstrate the
importance of Thr-205 in determining substrate specificity and product
formation as well as in influencing the susceptibility of P450 2B1 to
mechanism-based inactivators.
Address correspondence to: Dr. Paul F. Hollenberg, Department of Pharmacology, MSRB III, 1150 West Medical Center Dr., Ann Arbor, MI 48109-0632. E-mail: phollen{at}umich.edu
This article has been cited by other articles:
![]() |
B. K. Muralidhara, S. Negi, C. C. Chin, W. Braun, and J. R. Halpert Conformational Flexibility of Mammalian Cytochrome P450 2B4 in Binding Imidazole Inhibitors with Different Ring Chemistry and Side Chains: SOLUTION THERMODYNAMICS AND MOLECULAR MODELING J. Biol. Chem., March 24, 2006; 281(12): 8051 - 8061. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-l. Lin, U. M. Kent, and P. F. Hollenberg The Grapefruit Juice Effect Is Not Limited to Cytochrome P450 (P450) 3A4: Evidence for Bergamottin-Dependent Inactivation, Heme Destruction, and Covalent Binding to Protein in P450s 2B6 and 3A5 J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 154 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Lin, U. M. Kent, H. Zhang, L. Waskell, and P. F. Hollenberg The Functional Role of Threonine-205 in the Mechanism-Based Inactivation of P450 2B1 by Two Ethynyl Substrates: The Importance of the F Helix in Catalysis J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 855 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Scott, M. A. White, Y. A. He, E. F. Johnson, C. D. Stout, and J. R. Halpert Structure of Mammalian Cytochrome P450 2B4 Complexed with 4-(4-Chlorophenyl)imidazole at 1.9-A Resolution: INSIGHT INTO THE RANGE OF P450 CONFORMATIONS AND THE COORDINATION OF REDOX PARTNER BINDING J. Biol. Chem., June 25, 2004; 279(26): 27294 - 27301. [Abstract] [Full Text] [PDF] |
||||